ReviewInternational journal of molecular sciences2026
Adipose Tissue Heterogeneity: Depot-Specific Location and Functional Specialization in Obesity-Related Disease.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Adipose tissue is now recognized as a heterogeneous endocrine and metabolic organ rather than a passive lipid reservoir. Beyond the classical white, brown, and beige adipocytes, several depot- and organ-specific lipid-storing cell populations, including pink adipocytes, bone marrow (yellow) adipocytes, and hepatic stellate cells, contribute to energy homeostasis, thermogenesis, immune regulation, bone marrow function, and hepatic retinoid storage. Most existing reviews address these populations separately or focus narrowly on classical depots. Here, we integrate classical and non-classical adipocyte populations within a single depot-specific framework, examining how anatomical location and functional specialization jointly determine their contribution to obesity-related non-communicable diseases, including type 2 diabetes mellitus, metabolic-associated fatty liver disease, hypertension, and atherosclerotic cardiovascular disease. We further highlight unresolved mechanistic questions, including macrophage phenotypic heterogeneity beyond the classical M1/M2 model, the translational limits of brown adipose tissue activation, and the paracrine role of perivascular adipose tissue, that represent priority areas for future investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.